Metacognitive Therapy and Intolerance of Uncertainty Therapy for Generalized Anxiety Disorder in Primary Care: Randomized Controlled Pilot Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Generalized Anxiety Disorder
- Sponsor
- Karolinska Institutet
- Enrollment
- 64
- Locations
- 1
- Primary Endpoint
- Penn State Worry Questionnaire - Measure of Symptom Change
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The feasibilty and preliminary comparative effectiveness of two methods of cognitive-behavioral therapy - metacognitive therapy and intolerance of uncertainty therapy - for primary care patients with generalized anxiety disorder is investigated in a pilot study using a randomized controlled design. Purpose of the study is to examine the feasibility of a full-scale randomized controlled trial. Research questions primarily concern recruitment, measurement, and adherence.
Investigators
Benjamin Bohman
Dr
Karolinska Institutet
Eligibility Criteria
Inclusion Criteria
- •Primary diagnosis of generalized anxiety disorder
- •Age 18 years or above
- •Being able to understand and speak Swedish without interpreter support
Exclusion Criteria
- •Psychosis, bipolar disorder, severe depressive symptoms, risk of suicid, substance use disorder, intellectual disability
- •Simultaneous psychological treatment
- •If pharmacological treatment, it needs to be stable prior to and during treatment
Outcomes
Primary Outcomes
Penn State Worry Questionnaire - Measure of Symptom Change
Time Frame: Change from baseline symptoms at 12 weeks
Penn State Worry Questionnaire, a self-reported symptom measure of worry. Scale ranges: 16-80 scores on a scale; higher values represent a worse outcome.